Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for RLYB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 5.307M
March 31, 2026 5.290M
December 31, 2025 5.283M
September 30, 2025 5.242M
June 30, 2025 5.213M
March 31, 2025 41.61M
December 31, 2024 5.189M
September 30, 2024 41.49M
June 30, 2024 41.49M
March 31, 2024 37.81M
December 31, 2023 37.83M
September 30, 2023 37.80M
June 30, 2023 37.79M
Date Value
March 31, 2023 37.75M
December 31, 2022 37.84M
September 30, 2022 32.09M
June 30, 2022 32.13M
March 31, 2022 32.13M
December 31, 2021 32.13M
September 30, 2021 32.13M
June 30, 2021 26.57M
March 31, 2021 32.13M
December 31, 2020 4.016M
September 30, 2020 23.39M
June 30, 2020 7.558M
March 31, 2020 32.13M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Q32 Bio, Inc. 23.74M
Beam Therapeutics, Inc. 103.26M
C4 Therapeutics, Inc. 122.91M
Cullinan Therapeutics, Inc. 64.55M
Arrowhead Pharmaceuticals, Inc. 141.14M